syngo.CT CaScoring vs Tempus ECG-AF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

syngo.CT CaScoring

by Siemens Medical Solutions USA

Tempus ECG-AF

by Tempus AI, Inc.

AI Verdict

These tools are adjacent competitors, both focusing on cardiovascular risk assessment but utilizing different modalities and targeting distinct aspects of cardiac health. syngo.CT CaScoring analyzes CT scans to quantify coronary artery calcification for atherosclerotic risk, while Tempus ECG-AF analyzes ECGs to predict the risk of atrial fibrillation in older patients. Therefore, the choice depends on whether the clinical need is for structural assessment of coronary arteries or predictive risk of an arrhythmia.

Choose syngo.CT CaScoring if…

Choose syngo.CT CaScoring if you need to quickly and accurately quantify and visualize calcified coronary lesions from CT scans for cardiovascular risk assessment. This tool is ideal for assessing plaque burden in individual coronary arteries and comparing patient scores to healthy reference groups, aiding in the documentation and prognostic indication of atherosclerotic coronary heart disease.

View syngo.CT CaScoring →

Choose Tempus ECG-AF if…

Choose Tempus ECG-AF if you need an AI-based algorithm to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months from 12-lead ECG recordings. This tool is best suited for earlier identification and follow-up of AF in eligible patients, supporting proactive patient management and allowing for CMS reimbursement.

View Tempus ECG-AF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	syngo.CT CaScoring	Tempus ECG-AF
Pricing	Contact for pricing	Contact vendor
Deployment	Integrated with Siemens CT scanner systems; operates as a post-processing application on the multi-user syngo.via client/server platform.	Software solution, integrated into healthcare facility systems with advanced cardiology algorithms.
BAA Available	Unknown	Yes AI-estimated
FDA Status	1 AI-estimated	Yes AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

syngo.CT CaScoring

syngo.CT CaScoring offers a more interactive and user-friendly experience with features like automatic highlighting of calcifications, user-modifiable thresholds, and comparison to healthy reference groups, all integrated within the syngo.via platform. Tempus ECG-AF, while valuable, is described as not having a dedicated user interface and integrating via APIs, suggesting a less direct user interaction for clinicians.

Clinical Value

Tie

Both tools offer significant clinical value in their respective domains. syngo.CT CaScoring provides comprehensive quantification and visualization of coronary calcifications for cardiovascular risk assessment. Tempus ECG-AF identifies patients at increased risk of developing AF within 12 months, enabling earlier intervention. Both are FDA-cleared and address critical needs in cardiology.

Pricing & Value

Tempus ECG-AF

Tempus ECG-AF has a clear advantage in pricing transparency and value due to established CMS reimbursement (CPT 0764T and CPT 0765T to APC 5734, Medicare rate of $128.90, effective January 1, 2025). syngo.CT CaScoring requires contacting the vendor for pricing, with historical data suggesting a one-time license purchase that could be a significant upfront cost.

Enterprise Readiness

syngo.CT CaScoring

syngo.CT CaScoring is integrated with Siemens CT scanner systems and operates on the multi-user syngo.via client/server platform, indicating robust enterprise integration within existing radiology workflows. Tempus ECG-AF integrates into healthcare facility systems via software solutions and APIs, but its compatibility is limited to specific ECG machines, which might pose integration challenges in diverse environments.

Innovation

Tie

Both tools demonstrate innovation in applying AI to cardiovascular diagnostics. syngo.CT CaScoring uses AI for advanced image analysis and quantification of coronary calcifications. Tempus ECG-AF leverages AI for predictive risk assessment of atrial fibrillation from ECGs, a novel application for early identification.

Support & Docs

syngo.CT CaScoring

Siemens Healthineers, as a large medical solutions provider, offers extensive support and documentation for syngo.CT CaScoring, including a document library, education, and training through the Siemens Healthineers Academy. Tempus ECG-AF provides contact information for their cardiology support team, but the breadth of their documentation and educational resources is not as explicitly detailed.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	syngo.CT CaScoring	Tempus ECG-AF
Tool Name	syngo.CT CaScoring	Tempus ECG-AF
Company	Siemens Medical Solutions USA	Tempus AI, Inc.
Description	AI-powered image analysis software for quick quantification and accurate visualization of calcified coronary lesions from CT scans, aiding in cardiovascular risk assessment and documentation.	FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months, supporting earlier identification and follow-up.
Primary Function	Quantification and visualization of coronary calcifications from CT scans.	Identification of patients at increased risk of developing atrial fibrillation/flutter (AF) from 12-lead ECGs.

Videos

Demos, reviews, and walkthroughs featuring syngo.CT CaScoring and Tempus ECG-AF.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and EHR systems?

syngo.CT CaScoring integrates with Siemens CT scanner systems and operates on the syngo.via client/server platform, which supports workflow from case preparation to results sharing and can be accessed from various locations, including PACS. Tempus ECG-AF is designed to work with existing ECG platforms and EHRs, using EHR integrations and patient clinical data to filter eligible patients and surface precision care pathways at the point of care.

What are the accuracy and sensitivity metrics for each tool?

syngo.CT CaScoring demonstrates excellent accuracy with AI and expert CACS agreement (ICC = 0.951) and saves approximately 60% of time compared to manual review. Tempus ECG-AF demonstrated a sensitivity of 31% and a specificity of 92% for classifying patients who developed clinically recognized AF within one year. The positive predictive value was 19%, and the negative predictive value was 95%.

What is the learning curve for physicians adopting these AI tools?

syngo.CT CaScoring is a post-processing application on the syngo.via platform, which is designed for efficient workflow and reduced reading time, suggesting a streamlined learning curve for users familiar with Siemens systems. Tempus ECG-AF is designed to integrate into existing ECG platforms and EHRs without adding complexity, aiming for seamless adoption within established clinical workflows.

What kind of clinical context do these tools provide to aid physician decision-making?

syngo.CT CaScoring quantifies coronary calcifications, calculates Agatston score, volume, and calcium mass, and compares patient scores to healthy reference groups, providing a 'Coronary Age' for cardiovascular risk assessment. Tempus ECG-AF identifies patients aged 65 or older at increased risk of developing AF within 12 months, with results to be interpreted alongside other diagnostic information and clinical history, but not as a sole basis for diagnosis or treatment.

Are there audit-trail features available to track the use and results generated by these tools?

While specific audit-trail features are not detailed for syngo.CT CaScoring, the syngo.via platform emphasizes workflow integration and documentation of findings, which typically includes tracking mechanisms. Tempus ECG-AF integrates into healthcare facility systems and aims to surface precision pathways at the point of care and track patients for follow-up, implying underlying audit capabilities for patient journeys.

What are the considerations for rolling out these tools across multiple clinical sites?

syngo.CT CaScoring operates on the multi-user syngo.via client/server platform, which is designed for accessibility from virtually anywhere, including PACS, suggesting scalability for multi-site deployments. Tempus ECG-AF has undergone multi-site validation across geographically distinct clinical sites, demonstrating its consistent performance in varied clinical environments, which supports multi-site rollout.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring syngo.CT CaScoring or Tempus ECG-AF

Backers

Who funded each tool's parent company.